Scientists from Argenta Discovery and Almac Discovery will work together to advance one of Almac's high-value cancer programmes from hit identification to development candidate.
This is the result of the two companies entering into a fee-for-service collaboration.
Argenta will provide computational chemistry and medicinal chemistry services, while Almac will contribute medicinal chemistry, biochemistry and in vitro screening capabilities.
Argenta Discovery is a contract research and respiratory research and development company.
Almac Discovery discovers and develops treatments for cancer and associated conditions.
